DMAC DiaMedica Therapeutics Inc.

3.58
+0.06  (+2%)
Previous Close 3.52
Open 3.49
Price To Book 32.55
Market Cap 42805609
Shares 11,956,874
Volume 23,730
Short Ratio
Av. Daily Volume 76,555

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data due 4Q 2019 or 1Q 2020.
DM199 - Remedy
Acute ischaemic stroke
Phase 2 trial to be initiated 2019/2020.
DM199
Vascular dementia
Phase 1b dosing of first patient announced February 14, 2019.
DM199
Chronic Kidney Disease